Catheter Ablation of Atrial Fibrillation without Coumadin Discontinuation, Protects against Thromboembolic Complications

Summary

Evidence From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation trial [COMPARE; NCT01006876] confirms that the continuous use of warfarin while performing catheter ablation of AF significantly reduces the occurrence of periprocedural stroke/transient ischemic attack and bleeding complications [Di Biase L et al. Heart Rhythm 2013]. The results suggest that periprocedural anticoagulation management could play an important role in the occurrence of these complications.

  • Arrhythmias
  • Interventional Techniques & Devices
  • Cardiology Clinical Trials
  • Cardiology & Cardiovascular Medicine
View Full Text